POZAVIO Trademark

Trademark Overview

On Thursday, June 20, 2019, a trademark application was filed for POZAVIO with the United States Patent and Trademark Office. The USPTO has given the POZAVIO trademark a serial number of 88482035. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 11, 2022. This trademark is owned by Spectrum Pharmaceuticals, Inc.. The POZAVIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment
pozavio

General Information

Serial Number88482035
Word MarkPOZAVIO
Filing DateThursday, June 20, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 11, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer; pharmaceuticals for oncological treatment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSpectrum Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameSpectrum Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618

Trademark Events

Event DateEvent Description
Monday, July 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 10, 2021SOU EXTENSION 4 GRANTED
Friday, December 10, 2021SOU EXTENSION 4 FILED
Friday, December 10, 2021TEAS EXTENSION RECEIVED
Friday, June 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 9, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 9, 2021SOU EXTENSION 3 FILED
Wednesday, June 9, 2021TEAS EXTENSION RECEIVED
Wednesday, December 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 7, 2020SOU EXTENSION 2 GRANTED
Monday, December 7, 2020SOU EXTENSION 2 FILED
Monday, December 7, 2020TEAS EXTENSION RECEIVED
Friday, April 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 22, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 22, 2020SOU EXTENSION 1 FILED
Wednesday, April 22, 2020TEAS EXTENSION RECEIVED
Tuesday, December 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2019ASSIGNED TO EXAMINER
Monday, July 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 24, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

pozavio pharmaceuticals treatment oncological cancer